Pharmaceutical regulatory agencies and organization around the world scope and challenges in drug development
Bibliographic record
Abstract
Pharmaceutical regulatory agencies play a critical role in overseeing the development, approval, and post-market surveillance of medicines to ensure their safety, efficacy, and quality. Key agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), along with Health Canada and others, are responsible for regulating drug approval processes and enforcing standards across preclinical and clinical stages. These agencies also manage pharmacovigilance systems and promote innovation through fast-track approvals and special designations.This report explores the global scope of pharmaceutical regulation, highlighting regional differences and international harmonization efforts. It analyzes the challenges regulatory bodies face, including the integration of emerging medical technologies like biologics, gene therapies, and artificial intelligence, as well as the need to manage increasing volumes of data and respond to globalization. It also emphasizes the importance of coordinated regulatory frameworks, transparency, and scientific adaptability in the face of public health emergencies, counterfeit drugs, and evolving therapeutic landscapes.Overall, the study underscores that strong international collaboration, adaptive regulation, and commitment to scientific rigor are essential for regulatory agencies to keep pace with innovation and uphold their core mission of protecting public he.[1]
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.028 | 0.034 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.001 |
| Bibliometrics | 0.003 | 0.006 |
| Science and technology studies | 0.003 | 0.008 |
| Scholarly communication | 0.018 | 0.006 |
| Open science | 0.001 | 0.004 |
| Research integrity | 0.006 | 0.005 |
| Insufficient payload (model declined to judge) | 0.009 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".